Mycophenolate

Print page Reset all

What is mycophenolate?

Mycophenolate (full name mycophenolate mofetil and trade name CellCept) is a type of drug known as a disease-modifying anti-rheumatic drug (DMARD). These drugs have the effect of dampening down the underlying disease process, rather than simply treating symptoms. Mycophenolate reduces the activity of your body’s immune system, so it’s always used with care.

Find out more

Why is mycophenolate prescribed?

Mycophenolate is used to treat several different types of rheumatic conditions, including lupus, and diseases in which there’s inflammation of blood vessels, for example vasculitis.

Mycophenolate may also be used after organ transplantation, for example in kidney transplants.

Find out more

How do I take mycophenolate and how long does it take to work?

Mycophenolate is usually taken in capsule form twice a day. You should take the capsules with food or a glass of water and swallow them whole (not crush or chew them). Your doctor will advise you about the correct dose.

Mycophenolate doesn’t work immediately. It may be up to 3 months before you notice any benefit.

Find out more

What are the possible side-effects?

Side-effects include nausea (feeling sick), vomiting, diarrhoea and stomach pain. It can also make you more likely to develop infections.

Find out more

What are the risks?

There may be some risks in taking amycophenolate. This section gives important information about these risks, including the effects on:
  • your immune system
  • vaccinations
  • drinking alcohol
  • fertility and pregnancy
  • breastfeeding

Find out more

What else should I know about mycophenolate?

This section gives answers to some common questions about taking mycophenolate:
  • Are there any alternatives?
  • Will I need any special checks?
  • Can I take other medicines?

Find out more

Information for...
Download our information booklet on mycophenolate (563.5 KB)
Order the printed leaflet on mycophenolate

Search arthritis information

Related conditions

News
Lupus treatments 'have improved over last decade'
05 November 2010

Disease causing B cells in lupus - a new target for drug development?